肾素-血管紧张素系统基因多态性与动脉瘤性蛛网膜下腔出血的相关性
CARAS研究在美国2个学术中心前瞻性纳入149例动脉瘤性蛛网膜下腔出血患者和50例对照,检测肾素-血管紧张素系统常见基因多态性并测定血浆血管紧张素转换酶浓度。校正潜在混杂因素后,AGT C/T与AT2 G/A多态性均与动脉瘤性蛛网膜下腔出血无显著关联,但AT2 G/A的G等位基因显性效应呈现较强趋势。
要点
- 校正混杂因素后,AGT C/T与AT2 G/A多态性均与动脉瘤性蛛网膜下腔出血无显著关联。
- AT2 G/A的G等位基因显性效应对动脉瘤性蛛网膜下腔出血呈现较强趋势。
- II基因型患者血管紧张素转换酶水平显著低于ID和DD基因型患者。
核心结论
- 校正潜在混杂因素后,AGT C/T与AT2 G/A多态性均与动脉瘤性蛛网膜下腔出血无显著关联。
- AT2 G/A单核苷酸多态性G等位基因的显性效应呈现较强趋势。
- 局部肾素-血管紧张素系统下调可能参与脑动脉瘤形成及随后发生的动脉瘤性蛛网膜下腔出血。
- 需要进一步研究以阐明相关病理生理机制及其在动脉瘤性蛛网膜下腔出血患者治疗中的潜在意义。
研究设计与样本
- CARAS研究为前瞻性研究,在美国2个学术中心前瞻性纳入动脉瘤性蛛网膜下腔出血患者和对照。
- 共筛查248例患者,149例动脉瘤性蛛网膜下腔出血患者和50例对照可用于分析。
- 所有患者均采集血样进行基因评估并测定血浆血管紧张素转换酶浓度。
- 常见肾素-血管紧张素系统多态性采用5'核酸外切酶(TaqMan)基因分型分析和限制性片段长度多态性分析检测。
主要发现
- 血管紧张素原(AGT)C/T单核苷酸多态性C等位基因的隐性效应对动脉瘤性蛛网膜下腔出血的OR为1.94(95%CI 0.912-4.12,p=0.0853)。
- 血管紧张素II 2型受体(AT2)G/A单核苷酸多态性G等位基因的显性效应对动脉瘤性蛛网膜下腔出血的OR为2.11(95%CI 0.972-4.57,p=0.0590)。
- 上述关联在校正潜在混杂因素后均未达统计学显著。
- II基因型动脉瘤性蛛网膜下腔出血患者的血管紧张素转换酶水平为17.6±8.0 U/L,显著低于ID基因型的22.5±12.1 U/L和DD基因型的26.6±14.2 U/L(p=0.0195)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究以阐明相关病理生理机制及其在动脉瘤性蛛网膜下腔出血患者治疗中的潜在意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Renin-angiotensin system (RAS) genetic polymorphisms are thought to play a role in cerebral aneurysm formation and rupture. The Cerebral Aneurysm Renin-Angiotensin System (CARAS) study prospectively evaluated common RAS polymorphisms and their relation to aneurysmal subarachnoid hemorrhage (aSAH). METHODS The CARAS study prospectively enrolled aSAH patients and controls at 2 academic centers in the United States. A blood sample was obtained from all patients for genetic evaluation and measurement of plasma angiotensin-converting enzyme (ACE) concentration. Common RAS polymorphisms were detected using 5' exonuclease (TaqMan) genotyping assays and restriction fragment length polymorphism analysis. RESULTS Two hundred forty-eight patients were screened, and 149 aSAH patients and 50 controls were available for analysis. There was a recessive effect of the C allele of the angiotensinogen ( AGT) C/T single-nucleotide polymorphism (SNP) (OR 1.94, 95% CI 0.912-4.12, p = 0.0853) and a dominant effect of the G allele of the angiotensin II receptor Type 2 ( AT2) G/A SNP (OR 2.11, 95% CI 0.972-4.57, p = 0.0590) on aSAH that did not reach statistical significance after adjustment for potential confounders. The ACE level was significantly lower in aSAH patients with the II genotype (17.6 ± 8.0 U/L) as compared with the ID (22.5 ± 12.1 U/L) and DD genotypes (26.6 ± 14.2 U/L) (p = 0.0195). CONCLUSIONS The AGT C/T and AT2 G/A polymorphisms were not significantly associated with aSAH after controlling for potential confounders. However, a strong trend was identified for a dominant effect of the G allele of the AT2 G/A SNP. Downregulation of the local RAS may contribute to the formation of cerebral aneurysms and subsequent presentation with aSAH. Further studies are required to elucidate the relevant pathophysiology and its potential implication in treatment of patients with aSAH.
引用
- Griessenauer CJ, Tubbs RS, Foreman PM, et al. Association of renin-angiotensin system genetic polymorphisms and aneurysmal subarachnoid hemorrhage. J Neurosurg. 2017. PMID: 28106497. doi:10.3171/2016.9.JNS161593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。